115 related articles for article (PubMed ID: 3258536)
1. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia.
Lahat N; Aghai E; Kotler A; Kinarty A; Sobel E; Gruener N; Froom P
Blood; 1988 Apr; 71(4):1141-3. PubMed ID: 3258536
[TBL] [Abstract][Full Text] [Related]
2. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
[TBL] [Abstract][Full Text] [Related]
3. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
Griffiths SD; Cawley JC
Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
[TBL] [Abstract][Full Text] [Related]
4. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M
Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
Reiter Z; Tomson S; Ozes ON; Taylor MW
Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
[TBL] [Abstract][Full Text] [Related]
6. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
Abrams SI; Brahmi Z
Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
[TBL] [Abstract][Full Text] [Related]
7. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
Reiter Z; Ozes ON; Blatt LM; Taylor MW
J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
[TBL] [Abstract][Full Text] [Related]
9. Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
Cordingley FT; Hoffbrand AV; Brenner MK
Br J Haematol; 1988 Sep; 70(1):37-41. PubMed ID: 3140887
[TBL] [Abstract][Full Text] [Related]
10. Hairy cell leukemia cells are relatively NK-insensitive targets.
Starling GC; Nimmo JC; Hart DN
Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
[TBL] [Abstract][Full Text] [Related]
11. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
Griffiths SD; Cawley JC
Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
[TBL] [Abstract][Full Text] [Related]
12. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
[TBL] [Abstract][Full Text] [Related]
13. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
14. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
15. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
16. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.
de Fries RU; Golub SH
J Immunol; 1988 May; 140(10):3686-93. PubMed ID: 3129500
[TBL] [Abstract][Full Text] [Related]
18. A dual anti-tumor effect of a combination of interferon-alpha or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity.
Reiter Z; Ozes ON; Blatt LM; Taylor MW
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):103-11. PubMed ID: 1370257
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]